Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yujin Yinxie Tablets (郁金银屑片) is a traditional Chinese medicine (TCM) formulated as oral tablets. It is primarily indicated for the treatment of psoriasis (牛皮癣). The formulation is composed of multiple herbal and mineral ingredients, including Radix Gentianae Macrophyllae (秦艽), Radix Angelica Sinensis (当归), Rhizoma Acori Tatarinowii (石菖蒲), Cortex Phellodendri Amurensis (关黄柏), Rhizoma Cyperi (香附), Radix Curcumae (郁金), Rhizoma Curcumae (醋莪术), Realgar (雄黄), Semen Strychni (马钱子粉), Spina Gleditsiae (皂角刺), Semen Persicae (桃仁), Flos Carthami (红花), Olibanum (乳香), Halitum (硇砂), Natrii Sulfas Exsiccatus (玄明粉), Radix et Rhizoma Rhei (大黄), Eupolyphaga (土鳖虫), Indigo Naturalis (青黛), and Semen Momordicae (木鳖子). It functions by promoting blood circulation, resolving hard masses, clearing heat, detoxifying, dispelling dampness, and killing parasites. It is approved in China and manufactured by developers such as Xian Zhengda Pharmaceutical.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yujin Yinxie Tablets.